GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **326 - 350** of **4050** in total

« First

‹ Prev

…

10

11

12

13

14

15

16

17

18

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G02670IJ	254
IgM	Patient 3	4	mild	G02670IJ	252
IgA	Patient 4	12	mild	G02670IJ	476
IgG	Patient 4	12	mild	G02670IJ	93
IgM	Patient 4	12	mild	G02670IJ	514
IgA	Patient 1	10	moderate	G03499BP	391
IgA	Patient 1	22	moderate	G03499BP	343
IgA	Patient 1	6	moderate	G03499BP	378
IgG	Patient 1	10	moderate	G03499BP	32
IgG	Patient 1	22	moderate	G03499BP	36
IgG	Patient 1	6	moderate	G03499BP	36
IgM	Patient 1	10	moderate	G03499BP	60
IgM	Patient 1	22	moderate	G03499BP	73
IgA	Patient 2	15	mild	G03499BP	308
IgA	Patient 2	24	mild	G03499BP	386
IgG	Patient 2	15	mild	G03499BP	45
IgG	Patient 2	24	mild	G03499BP	61
IgM	Patient 2	15	mild	G03499BP	152
IgM	Patient 2	24	mild	G03499BP	229
IgM	Patient 1	6	moderate	G03499BP	61
IgA	Patient 2	3	mild	G03499BP	378
IgG	Patient 2	3	mild	G03499BP	71
IgM	Patient 2	3	mild	G03499BP	276
IgA	Patient 3	-180	mild	G03499BP	279
IgA	Patient 3	11	mild	G03499BP	443